First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial (2011)
- Authors:
- Autor USP: PINHATA, MARISA MARCIA MUSSI - FMRP
- Unidade: FMRP
- DOI: 10.1016/S1473-3099(10)70313-3
- Assunto: CRIANÇAS
- Language: Inglês
- Imprenta:
- Source:
- Título: The Lancet Infectious Diseases
- ISSN: 1473-3099
- Volume/Número/Paginação/Ano: v. 11, n. 4, p. 273-283, 2011
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
- Licença: other-oa
-
ABNT
BABIKER, A. et al. First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial. The Lancet Infectious Diseases, v. 11, n. 4, p. 273-283, 2011Tradução . . Disponível em: https://doi.org/10.1016/S1473-3099(10)70313-3. Acesso em: 10 jan. 2026. -
APA
Babiker, A., Castro nee Green, H., Compagnucci, A., Fiscus, S., Giaquinto, C., Gibbs, D., et al. (2011). First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial. The Lancet Infectious Diseases, 11( 4), 273-283. doi:10.1016/S1473-3099(10)70313-3 -
NLM
Babiker A, Castro nee Green H, Compagnucci A, Fiscus S, Giaquinto C, Gibbs D, Harper L, Harrison L, Hughes HD, McKinney R, Melvin A, Mofenson L, Saidi Y, Smith ME, Tudor-Williams G, Walker AS, Mussi-Pinhata MM. First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial [Internet]. The Lancet Infectious Diseases. 2011 ; 11( 4): 273-283.[citado 2026 jan. 10 ] Available from: https://doi.org/10.1016/S1473-3099(10)70313-3 -
Vancouver
Babiker A, Castro nee Green H, Compagnucci A, Fiscus S, Giaquinto C, Gibbs D, Harper L, Harrison L, Hughes HD, McKinney R, Melvin A, Mofenson L, Saidi Y, Smith ME, Tudor-Williams G, Walker AS, Mussi-Pinhata MM. First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial [Internet]. The Lancet Infectious Diseases. 2011 ; 11( 4): 273-283.[citado 2026 jan. 10 ] Available from: https://doi.org/10.1016/S1473-3099(10)70313-3 - Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-infected pregnant women and adverse infant outcomes
- Syphilis in HIV-infected mothers and infants
- Particularidades imunológicas do pré-termo extremo: um desafio para a prevenção da sepse hospitalar
- Etravirine in treatment-experienced, HIV-1-infected chidren and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study
- Lower respiratory tract infections and hospitalizations among HIV-exposed, uninfected infants born in Latin America
- Detecção qualitativa e quantitativa de partículas virais e anticorpos contra o vírus da Hepatite B (VHB) no sangue e leite de nutrizes AGHBS/Anti-HBc e anti-HBs/anti-HBc positivas
- Prevalência dos marcadores da infecção pelo vírus da hepatite B (VHB) em parturientes: destaque para detecção isolada do marcador anti-HBc
- Three postpartum antiretroviral regimens to prevent intrapartum HIV infection
- Birth prevalaence and characteristics of congenital toxoplasmosis in Sergipe, North-east Brazil
- Missed opportunities for prevention of mother-to-child transmission of HIV-1 in the NISDI perinatal and LILAC cohorts
Informações sobre o DOI: 10.1016/S1473-3099(10)70313-3 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
